Opinion: Tested in Africa, used in America
At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug in HIV prevention brought a raucous standing ovation. Lenacapavir, a novel drug given as an injection under the skin every six months, was 100% successful in preventing HIV in adolescent girls and young women in two countries in Africa.
It felt to many like a generational moment. After years of failed vaccine trials, this was something nearly as valuable — a shot given twice yearly that substantially prevents HIV infections. That the drug was so beneficial in young women in Africa made the finding particularly monumental.
Read Original Article: Opinion: Tested in Africa, used in America »
